Rheumatology: May 2010 Archives

The Best-Seller Dance

By bmartin on May 4, 2010 8:45 AM |

By using newly released data from Thomson Reuters (for 2010 and 2014) and EvaluatePharma (for 2016), a timeline graphic of the 7 drugs that are expected to remain within the top 10 best sellers is presented. Notably only 1 of the 7, Crestor, is a conventional pill.

 

Best_sellers.pngAdvair (fluticasone/salmeterol; GSK) and Remicade (infliximab; Centocor Ortho Biotech) lose position, while the other drugs are expected to rise on the list. The future top seller, depending on your source, is Humira (adalimumab; Abbott) or Avastin (bevacizumab; Roche).

« Rheumatology: December 2009 | Main Index | Archives | Rheumatology: April 2011 »

About this Archive

This page is a archive of entries in the Rheumatology category from May 2010.

Rheumatology: December 2009 is the previous archive.

Rheumatology: April 2011 is the next archive.

Find recent content on the main index or look in the archives to find all content.

Rheumatology: May 2010: Monthly Archives

Powered by Movable Type 4.01